Agenda.
- Agenda -
Thursday 18th April 2024
1200-1245
Arrival Lunch & Registration
1245-1250
Welcome Address
Mr Eamonn Rogers, University Hospital Galway
Chairs:
Dr Moya Cunningham, St James’s Hospital, Dublin & Dr Petra Martin, Midland Regional Hospital, Tullamore
1250 - 1300
The Patient Journey
Gerry Kelly - Patient Advocate
1300 - 1320
Epigenetic Profiling of Aggressive Prostate Cancer
Dr Antoinette Perry
University College Dublin
1320 - 1340
Robotic RPLND: A SAFER Approach to Complex Surgery
Mr Ben Challacombe
Guy’s & St Thomas’ Hospitals
1340 - 1400
The Optimal Management of Unfavourable Risk Localized Prostate Cancer
Prof Andrew Loblaw
Sunnybrook Health Sciences Centre, University of Toronto
1400 - 1420
Prostate Cancer Screening, From Trial to Program
Prof Monique Roobul
Erasmus Medical Centre, Rotterdam
1420 - 1440
The Critical Importance of Understanding Prognosis When Counselling Men with Newly Diagnosed Prostate Cancer
Prof Vincent Gnanapragasam
University of Cambridge
1440 - 1500
The Genomics of Prostate Cancer
Dr Wassim Abida
MSKCC, New York
1500 - 1530
Panel Discussion - Renal
Chair: Prof Jack Gleeson, Cork University Hospital
1530 - 1600
Coffee Break
Chairs:
Dr Miriam O’Connor, Waterford Hospital Waterford & Mr Stephen Connolly, Mater Misericordiae University Hospital, Dublin
1600 - 1620
Testis Cancer Update
Dr Deaglan McHugh
MSKCC, New York
1620 – 1640
Radiomics-Enhancing Data Through Medical Imaging
Dr Michelle Leech
Trinity College, Dublin
1640 - 1700
Revisiting Neoadjuvant Therapy Prior To Radical Prostatectomy
Prof Neil Fleshner
University of Toronto
1700 - 1720
PSMA Theranostics in Advanced Prostate Cancer
Prof Joe O’Sullivan
Queen’s University, Belfast
1720 - 1740
Systemic Therapy in Advanced Urothelial Carcinoma of the Bladder
Dr Rob Jones
The Beatson West of Scotland Cancer Centre, Glasgow
1740 - 1815
Panel Discussion- Bladder
Chair: Catherine Dowling, University Hospital Galway
Participants: Prof Neil Fleshner, Mr Matthew Perry, Prof Peter Hoskin
1815
End of Day 1
Friday 19th April 2024
Chairs:
Anita Cahill, Cork University Hospital & Prof Kilian Walsh, University Hospital, Galway
0830 - 0850
Trimodal Bladder Preservation From A Cystectomist’s Perspective
Prof Neil Fleshner
University of Toronto
0850 - 0910
PIONEER and OPTIMA - EU Funded Programmes on Big Data & AI in Prostate Cancer
Dr Anders Bjartell
Lund University, Sweden
0910 - 0930
Health Literacy and its Importance Among Cancer Caregivers
Chloe Moore
Dublin City University
0930 - 0950
An Evidence Based Approach to Risk Stratified Active Surveillance Management of Early Prostate Cancer
Prof Vincent Gnanapragasam
University of Cambridge
0950 - 1010
Peri-Operative Systemic Therapy for Renal Cell Carcinoma – Past, Present & Future
Dr Niamh Peters
University Hospital Limerick
1010 - 1030
Management of Oligometastatic Hormone Sensitive Prostate Cancer
Prof Andrew Loblaw
Sunnybrook Health Sciences Centre, University of Toronto
1030 - 1100
Coffee Break
Chairs:
Dr Gerard McVey, St Vincent’s University Hospital, Dublin & Mr Gregory Nason, Mater Misericordiae University Hospital, Dublin
1100 - 1110
The Patient Journey
Aiden Kenny - Patient Advocate
1110 - 1130
ProEx – The Prostate Cancer Centre of Excellence at Queen’s University Belfast
Prof Joe O’Sullivan
Queen’s University, Belfast
1130 - 1150
Digital Pathology & AI
Prof Clare Verrill
University of Oxford
1150 - 1210
The Royal Surrey Robotic Cystectomy Program; A Decade of Learning
Mr Matthew Perry
The Royal Surrey County Hospital
1210 - 1230
Cancer Rehabilitation and Exercise in Prostate Cancer
Dr Emer Guinan
Trinity College Dublin
1230 - 1250
PARP Inhibitors in the Treatment of Prostate Cancer: Current Use & Future Avenue
Dr Wassim Abida
MSKCC, New York
1250 - 1400
Lunch
Chairs:
Prof Michelle McNicholas, Mater Misericordiae University Hospital, Dublin & Dr Richard Bambury, Cork University Hospital
1400 - 1420
Community Oncology Clinic
Noeleen Sheridan
HSE, Ireland
1420 - 1440
Giant Cell Tumour Update
Dr Deaglan McHugh
MSKCC, New York
1440 - 1500
Radiotherapy for Bladder cancer: Evidence vs Practice
Prof Peter Hoskin
The Christie Hospital, Manchester
1500 - 1520
HUGO RAS-UK’s First Experience Of Integrating A New Robotic Platform Into An Existing High Volume Cancer Centre
Mr Ben Challacombe
Guy’s & St Thomas’ Hospitals
1520 - 1600
Panel Discussion- Prostate
Chair: Dr Richard Bambury, Cork University Hospital
Participants: Mr Ben Challacombe, Prof Vincent Gnanapragasam & Prof Andrew Loblaw
1600
End of Proceedings